Skip to main content
. 2022 Mar 28;13:59. doi: 10.1186/s13244-022-01199-3

Fig. 1.

Fig. 1

Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 2020 flow diagram for literature search. csPCa, clinically significant prostate cancer; iPCa, indolent prostate cancer